Gene tagging and its role in glioma recurrence
- Researcher: Dr Giuseppe Testa
- Institution: Istituto Europeo di Oncologia, Milan, Italy
- Award Amount: £136,500 for 3 years from October 2013
- Cancer Type: Brain Tumour
Dr Testa will be continuing the research from a previous Worldwide Cancer Research grant where he has been investigating how methylation of histone H3, a gene scaffolding protein, is involved in the development of glioma. Gliomas are the most common type of brain tumour, and they are made up of a group of 3 different types of brain tumours, which includes glioblastoma multiforme (GBM).
Dr Testa and his team found a window of time during GBM development, in which tumour growth was dependent on a specific pattern of methylation on histone H3. They want to continue this work with their new grant, by studying how these gene tags are involved in gliomas recurring. They will be using tissue samples from GBM patients. Surgery is becoming less frequent when GBM recurs, so these samples are a unique opportunity to study the relationship between gene tagging and the development of the disease. They will use an innovative combination of computer analysis and lab experiments to study gene networks involved in this disease. This research will hopefully give us a better understanding of how gene tagging affects different stages of the disease.
Showing: All projects
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.
Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....Read more